These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 3674773)

  • 1. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early oral contraceptive use as a prognostic factor in breast cancer.
    Olsson H; Möller TR; Ranstam J; Borg A; Fernö M
    Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
    Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
    Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in breast cancer and age at start of oral contraceptive usage.
    Ranstam J; Olsson H; Garne JP; Aspegren K; Janzon L
    Anticancer Res; 1991; 11(6):2043-6. PubMed ID: 1776838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and breast cancer.
    Gay JW; Cardwell MS
    Mo Med; 1990 Oct; 87(10):763-7. PubMed ID: 2259330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pill and the breast.
    Drife JO
    IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of oral contraceptives and the risk of breast cancer.
    Webster L
    J Reprod Med; 1986 Jun; 31(6 Suppl):540-5. PubMed ID: 3723486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.
    Olsson H; Borg A; Fernö M; Möller TR; Ranstam J
    Cancer Detect Prev; 1991; 15(4):265-71. PubMed ID: 1794133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The contraceptive pill and cancer].
    Lancet M
    Harefuah; 1990 Dec; 119(12):432-7. PubMed ID: 2074068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.
    McTiernan A; Thomas DB; Johnson LK; Roseman D
    J Natl Cancer Inst; 1986 Oct; 77(4):849-54. PubMed ID: 3463818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
    Brzezinski A; Schenker JG
    Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IPPF statement on oral contraceptives and cancer of the breast.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.